Organon Takeover Too Costly and Complicated, Says Merck & Co., Inc.; Merck Plans to Close R&D and Production Line with the Loss of Over 2,000 Jobs

Dutch News -- US pharmaceuticals giant Merck turned down an offer for its Organon unit in Oss because it would cost the company $700m more than closing it down, the company told a court hearing on Friday.